| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/16/2002 | EP1248602A2 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 10/16/2002 | EP1248601A1 Control of microbial populations in the gastrointestinal tract of animals |
| 10/16/2002 | EP1248600A1 Improved pharmaceutical formulations |
| 10/16/2002 | EP1248599A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 10/16/2002 | EP1248597A1 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| 10/16/2002 | EP1248595A1 Multi-step drug dosage forms |
| 10/16/2002 | EP1248594A1 Multi-spike release formulation for drug delivery |
| 10/16/2002 | EP1248591A1 Anti-microbial compositions comprising a salt of a transition metal chelator |
| 10/16/2002 | EP1248516A2 38 human secreted proteins |
| 10/16/2002 | EP1206574A4 Guanidinium functionalized oligomers and methods |
| 10/16/2002 | EP1173521B1 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same |
| 10/16/2002 | EP1159279B1 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 10/16/2002 | EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease |
| 10/16/2002 | EP1089737B1 Levosimendan for treating pulmonary hypertension |
| 10/16/2002 | EP1085860B1 Formulations for the treatment of gastro-oesophageal reflux |
| 10/16/2002 | EP0998279B1 Pharmaceutical injection solution containing taxol |
| 10/16/2002 | EP0991653B1 Novel compounds |
| 10/16/2002 | EP0975632B1 Alkaloid halide salts of swainsonine and methods of use |
| 10/16/2002 | EP0973794B1 Netrin receptors |
| 10/16/2002 | EP0949927B1 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
| 10/16/2002 | EP0948509B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 10/16/2002 | EP0944596B1 1-acryloylindoline derivatives and their use as prodrugs of anticancer agents |
| 10/16/2002 | EP0944385B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 10/16/2002 | EP0941218B1 Antithrombotic organic nitrates |
| 10/16/2002 | EP0941108B1 Wound healing and treatment of fibrosis |
| 10/16/2002 | EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 10/16/2002 | EP0932400B1 Anticonvulsant derivatives useful in treating neuropathic pain |
| 10/16/2002 | EP0927161B1 Substituted cyclic amine metalloprotease inhibitors |
| 10/16/2002 | EP0920434B1 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
| 10/16/2002 | EP0914078B1 The use of l-lysine in the treatment of hair loss |
| 10/16/2002 | EP0910354B1 Antioxidant compounds |
| 10/16/2002 | EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 10/16/2002 | EP0891365B1 Benzoxazines for enhancing synaptic responses |
| 10/16/2002 | EP0877605B1 Solid instant-release forms of administration and process for producing the same |
| 10/16/2002 | EP0868429B1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 10/16/2002 | EP0844881B1 Laxative comprising lactitol and psyllium |
| 10/16/2002 | EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 10/16/2002 | EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 10/16/2002 | EP0812193B1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent |
| 10/16/2002 | EP0808168B1 Pharmaceutical composition for the treatment of herpes |
| 10/16/2002 | EP0802731B1 Prophylactic treatment of allergic contact dermatitis |
| 10/16/2002 | EP0789559B2 Pharmaceutical composition containing a fusible carrier and method for producing the same |
| 10/16/2002 | EP0763033B1 Imidazole derivatives and processes for the preparation thereof |
| 10/16/2002 | EP0741567B1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds |
| 10/16/2002 | EP0728205B1 Reagent for treatment of arthritic conditions |
| 10/16/2002 | EP0641203B1 Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists |
| 10/16/2002 | EP0637976B2 Medicament for disinfection of the oral cavity |
| 10/16/2002 | EP0637965B1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 10/16/2002 | EP0619742B1 Transfection of lung via aerosolized transgene delivery |
| 10/16/2002 | EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents |
| 10/16/2002 | EP0538477B1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient |
| 10/16/2002 | EP0538297B9 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones |
| 10/16/2002 | EP0528978B1 Mikrocaspules for controlled release and their use to stimulate nerve fiber growth |
| 10/16/2002 | CN1375058A Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures |
| 10/16/2002 | CN1375004A Methods and compsotions for inhibiting the function of polynucleotide sequences |
| 10/16/2002 | CN1374969A FAP-activated anti-tumor compounds |
| 10/16/2002 | CN1374968A 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, method fo r producing the same, medicaments containing these compounds and their use |
| 10/16/2002 | CN1374967A Compounds for the treatment of ischemia |
| 10/16/2002 | CN1374966A 嘌呤衍生物 Purine derivatives |
| 10/16/2002 | CN1374963A Remedies or preventives for freqent urination or arinary incontinence |
| 10/16/2002 | CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 10/16/2002 | CN1374961A Azepinoindole derivatives, the production and use thereof |
| 10/16/2002 | CN1374960A Novel integrain receptor antagonists |
| 10/16/2002 | CN1374959A Piperidine quinolyl propyl derivatives, preparation method and compositions containing same |
| 10/16/2002 | CN1374957A Benzopyran derivative |
| 10/16/2002 | CN1374956A 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof and their use as anticonvulsants |
| 10/16/2002 | CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents |
| 10/16/2002 | CN1374954A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds |
| 10/16/2002 | CN1374953A Aromatic nitrogenous six-membered ring compounds |
| 10/16/2002 | CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors |
| 10/16/2002 | CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 10/16/2002 | CN1374949A 毒蕈碱拮抗剂 Muscarinic antagonist |
| 10/16/2002 | CN1374948A 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same |
| 10/16/2002 | CN1374874A Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 10/16/2002 | CN1374872A Stabilization of macrolides |
| 10/16/2002 | CN1374867A Quetiapine granules |
| 10/16/2002 | CN1374866A Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 10/16/2002 | CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough |
| 10/16/2002 | CN1374864A Prevention and therapeutic agents for cancer |
| 10/16/2002 | CN1374863A Bicyclic antagonists selective for the alpha beta integrin |
| 10/16/2002 | CN1374862A Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 10/16/2002 | CN1374861A Methods for modulating the human sexual response |
| 10/16/2002 | CN1374860A Utilization of a highly fluorinated oligomeric alkan in ophthalmology |
| 10/16/2002 | CN1374859A 药物粉剂 Drug powder |
| 10/16/2002 | CN1374858A For mulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 10/16/2002 | CN1374857A Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 10/16/2002 | CN1374839A Potassium calcium citrate compositions and methods for production |
| 10/16/2002 | CN1374835A Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 10/16/2002 | CN1374314A Amorphous Adefuweizhi ester amorphous solid matter and its prepn |
| 10/16/2002 | CN1374309A Application of cinidium general coumarin as psoriasis treating medicine |
| 10/16/2002 | CN1374308A Antineoplastic active compound nitrene-phin and its prepn |
| 10/16/2002 | CN1374305A Alkoxy derivative of safrole oxide 2-alkoxy-piperonyl ethanol and its prepn and application |
| 10/16/2002 | CN1374300A Resin process of eliminating ginkgolic acid from gingko leaf extractive |
| 10/16/2002 | CN1374288A Gronwell naphthaquinone derivative and its application in preparing anticancer medicine |
| 10/16/2002 | CN1374089A New ass hide gelatin prepn and its prepn process |
| 10/16/2002 | CN1374088A Bcl-2 gene antisense nucleic acid medicine for resisting leukemia and tumor drug-fast |
| 10/16/2002 | CN1374087A Specific compound cold treating medicine |
| 10/16/2002 | CN1374086A Neutrocyte functional inhibitor |
| 10/16/2002 | CN1374085A Externally used and ophthalmic gel prepn of levo ofloxacin |
| 10/16/2002 | CN1374084A Lauryl piperazine, lauryl diethanolamine and the application of their derivatives in extracorporeal marrow purification |